Leadership Team
Meet Our Team
Board of Directors and Officers

Steve McBee
President and Co-founder
Steve McBee is a co-founder and board member of the Solitary Fibrous Tumor Foundation. A long-term SFT patient and advocate, Steve brings more than 20 years of experience in the SFT community, along with a background in entrepreneurship, brand strategy, communications, and community-building. He is the founder and CEO of Superdeluxe, a branded merchandise agency.
.jpg)
Dina Rollman
Vice President and Co-founder
Dina Rollman is a co-founder and board member of the Solitary Fibrous Tumor Foundation. She brings legal, business, governance, and nonprofit leadership experience to the foundation’s early development. Dina is helping guide SFTF’s legal formation, governance structure, and organizational foundation.

Bethany Lucas
Secretary
Bethany Lucas is a board member of the Solitary Fibrous Tumor Foundation. She is an associate professor at Regis University, where she teaches in biology, biomedical sciences, genetics, and genomics. As both a scientist and SFT patient, Bethany brings scientific training and lived experience to the foundation.

Marvin Schuldiner
Treasurer
Marvin Schuldiner is a board member of the Solitary Fibrous Tumor Foundation. He brings experience in mediation, arbitration, business problem-solving, and organizational process. His background supports SFTF’s early work in governance, board operations, and practical decision-making.

Steve Ducòs
Director
Steve Ducòs is a board member of the Solitary Fibrous Tumor Foundation. As an SFT patient, he brings lived experience along with a professional background in healthcare communications, multicultural marketing, partnerships, equity, and patient-centered outreach.
.jpg)
Sydney Zacher
Director
Sydney Zacher is a board member of the Solitary Fibrous Tumor Foundation. She brings a clinical research background and a personal connection to the SFT community through her family’s experience with the disease. Her perspective helps connect patient and caregiver priorities with research participation and patient engagement.